These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 35851115)
21. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711 [TBL] [Abstract][Full Text] [Related]
22. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles. Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157 [TBL] [Abstract][Full Text] [Related]
30. Protein inhalation powders: spray drying vs spray freeze drying. Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310 [TBL] [Abstract][Full Text] [Related]
31. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727 [TBL] [Abstract][Full Text] [Related]
32. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose. Amaro MI; Tajber L; Corrigan OI; Healy AM Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469 [TBL] [Abstract][Full Text] [Related]
33. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols. Kaewjan K; Srichana T Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092 [TBL] [Abstract][Full Text] [Related]
34. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131 [TBL] [Abstract][Full Text] [Related]
35. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation. Lu W; Rades T; Rantanen J; Chan HK; Yang M Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523 [TBL] [Abstract][Full Text] [Related]
36. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders. Yu J; Romeo MC; Cavallaro AA; Chan HK Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904 [TBL] [Abstract][Full Text] [Related]
37. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose. Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921 [TBL] [Abstract][Full Text] [Related]
38. Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation. Mangal S; Xu R; Park H; Zemlyanov D; Shetty N; Lin YW; Morton D; Chan HK; Li J; Zhou QT Pharm Res; 2018 Nov; 36(1):6. PubMed ID: 30406281 [TBL] [Abstract][Full Text] [Related]
39. Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement. Zhao Z; Huang Z; Zhang X; Huang Y; Cui Y; Ma C; Wang G; Freeman T; Lu XY; Pan X; Wu C Expert Opin Drug Deliv; 2018 May; 15(5):443-457. PubMed ID: 29532682 [TBL] [Abstract][Full Text] [Related]
40. Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug. Momin MAM; Tucker IG; Doyle CS; Denman JA; Das SC Int J Pharm; 2018 May; 543(1-2):318-327. PubMed ID: 29626509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]